iangxi Nuobang Bio operates two standardized veterinary drug production bases—the original Zhouzhuang plant in Jinxi and the new high-tech plant in the western urban district—covering a total building area of 20,000 square meters and featuring 23 production lines capable of manufacturing a full range of veterinary drug dosage forms. Having passed the inspection for the latest version of Veterinary Drug GMP in 2021, the company ranks at the forefront of Jiangxi’s animal health industry in terms of infrastructure capabilities. The two plants have distinct operational roles: the original plant focuses on conventional formulations such as powders, granules, disinfectants, and feed additives, while the new plant—equipped with Class 10,000 sterile cleanrooms—specializes in high-end formulations including injections, sterile powders for injection, ointments, and eye drops. The facilities are equipped with fully automated production machinery, an independent third-party quality inspection center, and a standardized Traditional Chinese Medicine (TCM) extraction workshop, all operating under a comprehensive, standardized quality control system. Integrating in-house product manufacturing, OEM services for veterinary and pet medicines, and contract manufacturing for export, the company achieves an annual production value exceeding 500 million RMB, standing as a leading, large-scale modern animal health production base in the province with the most extensive range of dosage forms.link:https://www.nuobangbio.com
